Quick Takeaways
- Carlyle Group Inc. filed SCHEDULE 13D/A for Spruce Biosciences, Inc. Common Stock, par value $0.0001 per share (SPRB).
- Disclosed ownership: 4.7%.
- Date of event: 18 Feb 2026.
Quoteable Key Fact
"Carlyle Group Inc. disclosed 4.7% ownership in Spruce Biosciences, Inc. Common Stock, par value $0.0001 per share (SPRB) on 18 Feb 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| The Carlyle Group Inc. | 4.7% | 50,893 | 0 | 50,893 | /s/ Anne K. Frederick | Anne K. Frederick, Corporate Secretary | 0001527166 |
| Carlyle Holdings I GP Inc. | 4.7% | 50,893 | 0 | 50,893 | /s/ Anne K. Frederick | Anne K. Frederick, Managing Director | 0001548626 |
| Carlyle Holdings I GP Sub L.L.C. | 4.7% | 50,893 | 0 | 50,893 | By: Carlyle Holdings I GP Inc., its sole member, /s/ Anne K. Frederick | Anne K. Frederick, Managing Director | 0001548627 |
| Carlyle Holdings I L.P. | 4.7% | 50,893 | 0 | 50,893 | /s/ Anne K. Frederick | Anne K. Frederick, Managing Director | 0001548628 |
| CG Subsidiary Holdings L.L.C. | 4.7% | 50,893 | 0 | 50,893 | /s/ Anne K. Frederick | Anne K. Frederick, Managing Director | 0001790577 |
| TC Group, L.L.C. | 4.7% | 50,893 | 0 | 50,893 | /s/ Anne K. Frederick | Anne K. Frederick, Managing Director | 0000933790 |
| Carlyle Investment Management L.L.C. | 4.7% | 50,893 | 0 | 50,893 | /s/ Anne K. Frederick | Anne K. Frederick, Managing Director | 0001354120 |
| Carlyle Genesis UK LLC | 4.7% | 50,893 | 0 | 50,893 | By: Carlyle Investment Management L.L.C., its sole member, /s/ Anne K. Frederick | Anne K. Frederick, Managing Director | 0001941860 |
| Abingworth LLP | 4.7% | 50,893 | 0 | 50,893 | /s/ Emma O'Reilly | Emma O'Reilly, Authorized Signatory | 0001397144 |
| Abingworth Bioventures VII LP | 4.7% | 50,893 | 0 | 50,893 | /s/ Emma O'Reilly | Emma O'Reilly, Authorized Signatory | 0001688313 |